Prevail Therapeutics Inc.

Report date
12/31/2020
Quarter
2020 Q4
Filed
5/24/2024
Shares
6,723
Value ($000)
155
Weight
0.0%
2020 Q1 - 2020 Q4 (3 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).